His scientific interests lie mostly in Breast cancer, Internal medicine, Radiation therapy, Oncology and Surgery. His Breast cancer research incorporates elements of Randomized controlled trial and Chemotherapy. In his work, Letrozole is strongly intertwined with Gynecology, which is a subfield of Internal medicine.
Timothy J. Whelan interconnects Meta-analysis and Systemic therapy in the investigation of issues within Radiation therapy. His Oncology research is multidisciplinary, incorporating elements of Prospective cohort study, Interquartile range, Incidence and Adjuvant therapy. His research integrates issues of Absolute risk reduction, Axillary lymph nodes, Lumpectomy and Heart disease in his study of Surgery.
His main research concerns Breast cancer, Internal medicine, Oncology, Radiation therapy and Surgery. His study in Breast cancer is interdisciplinary in nature, drawing from both Stage and Randomized controlled trial. In his research on the topic of Internal medicine, Letrozole is strongly related with Gynecology.
His studies in Oncology integrate themes in fields like Clinical endpoint, Proportional hazards model, Hazard ratio, Hormonal therapy and Adjuvant therapy. His Radiation therapy research is multidisciplinary, incorporating perspectives in Whole Breast Irradiation, Lumpectomy and Medical physics. His Surgery research includes themes of Colorectal cancer and Breast pain.
Timothy J. Whelan mostly deals with Breast cancer, Internal medicine, Oncology, Radiation therapy and Randomized controlled trial. Breast cancer is a subfield of Cancer that Timothy J. Whelan explores. In his study, which falls under the umbrella issue of Internal medicine, Metformin and Gastroenterology is strongly linked to Placebo.
His Oncology research incorporates themes from Meta-analysis, Tamoxifen and Clinical trial. His research in Radiation therapy intersects with topics in Absolute risk reduction, Ductal carcinoma, Interquartile range and Lumpectomy. His Randomized controlled trial study is associated with Surgery.
His primary areas of study are Breast cancer, Internal medicine, Oncology, Radiation therapy and Cancer. His primary area of study in Breast cancer is in the field of Mastectomy. The various areas that Timothy J. Whelan examines in his Oncology study include Chemotherapy, Adjuvant therapy, Meta-analysis, Proportional hazards model and Stage.
His Radiation therapy study integrates concerns from other disciplines, such as Lung cancer, Interquartile range, Lumpectomy and Whole Breast Irradiation. His studies deal with areas such as Gene expression profiling and Pathology as well as Cancer. His work carried out in the field of Surgery brings together such families of science as McNemar's test and Deep inspiration breath-hold.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango)
Cathy Charles;Amiram Gafni;Tim Whelan.
Social Science & Medicine (1997)
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials
S Darby;P McGale;C Correa.
The Lancet (2011)
Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model.
Cathy Charles;Amiram Gafni;Tim Whelan.
Social Science & Medicine (1999)
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Timothy J Whelan;Jean-Philippe Pignol;Mark N Levine;Jim A Julian.
The New England Journal of Medicine (2010)
Developing a quality criteria framework for patient decision aids: online international Delphi consensus process
Glyn Elwyn;Annette O'Connor;Dawn Stacey;Robert Volk.
(2006)
American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004
Eric P. Winer;Clifford Hudis;Harold J. Burstein;Antonio C. Wolff.
Journal of Clinical Oncology (2002)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Joseph A. Sparano;Robert J. Gray;Della F. Makower;Kathleen I. Pritchard.
The New England Journal of Medicine (2018)
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
P McGale;C. Taylor;C Correa.
The Lancet (2014)
Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers
Eva Grunfeld;Doug Coyle;Timothy Whelan;Jennifer Clinch.
Canadian Medical Association Journal (2004)
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano;R. J. Gray;D. F. Makower;K. I. Pritchard.
The New England Journal of Medicine (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
McMaster University
University of Toronto
McMaster University
McMaster University
BC Cancer Agency
Harvard University
University of Michigan–Ann Arbor
Albert Einstein College of Medicine
University of Calgary
University of Toronto
University of California, San Francisco
University of Oxford
Chinese Academy of Sciences
City University of New York
Los Alamos National Laboratory
Virginia Commonwealth University
Université Paris Cité
San Francisco State University
University of Paris-Saclay
University of Oxford
Utrecht University
Tehran University of Medical Sciences
University of Melbourne
Brown University
Centre for Addiction and Mental Health
Concordia University